Equities research analysts at StockNews.com assumed coverage on shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) in a report issued on Thursday. The brokerage set a “sell” rating on ...
Lexicon announced Wednesday (March 19) plans to expand its corporate headquarters and steel fabrication operations in Little ...
A major steel fabrication and construction company is investing $37.6 million to expand their headquarters and operations in ...
LITTLE ROCK, Ark. – Little Rock company Lexicon is gearing up to expand its operations in the capital city, creating more job ...
Lexicon plans to expand its corporate headquarters and steel fabrication operations in Little Rock, Arkansas, creating 60 new ...
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) has received a consensus rating of “Hold” from the five ratings ...
“In 2024, Lexicon made progress on our Lead to Succeed strategy, resulting in a complete repositioning of the company to focus on advancing our R&D pipeline,” said Mike Exton, Ph.D., Lexicon’s chief ...
THE WOODLANDS, Texas, March 07, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the Leerink ...
Lexicon has announced plans to expand its corporate headquarters and steel fabrication operations in Little Rock, Arkansas, creating 60 new jobs. The expansion represents a capital investment of $37.6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback